Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Monocentric, randomised, double-blind, placebo-controlled pilot study in double-dummy design in overweight or obese patients to compare two treatment regimes (Polyglucosamine L112 vs. Orlistat 60 mg)

Trial Profile

Monocentric, randomised, double-blind, placebo-controlled pilot study in double-dummy design in overweight or obese patients to compare two treatment regimes (Polyglucosamine L112 vs. Orlistat 60 mg)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 28 May 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Orlistat (Primary) ; Polyglucosamine L112
  • Indications Obesity; Overweight
  • Focus Registrational; Therapeutic Use
  • Sponsors Certmedica International
  • Most Recent Events

    • 02 Jun 2012 Planned number of patients changed from 40 to 60 as reported by European Clinical Trials Database.
    • 02 Jun 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-001692-30).
    • 07 Sep 2011 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top